Tuesday, October 20, 2020 10:52:36 AM
New York Yankees and Duke Basketball
Recent LQDA News
- Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) • GlobeNewswire Inc. • 06/18/2024 12:42:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 01:25:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 01:24:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:30:28 AM
- District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:00:48 PM
- Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:30:43 PM
- Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 09:43:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:10:36 PM
- Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Liquidia Corporation to Present at BofA Securities Health Care Conference 2024 • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 01:00:10 PM
- Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 04/01/2024 10:00:44 AM
- Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 11:30:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:07:54 AM
- Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress • GlobeNewswire Inc. • 01/30/2024 11:30:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:01:42 PM
- Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 01/25/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 12:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 12:01:41 PM
- Liquidia Corporation Announces Updates to Operations Leadership • GlobeNewswire Inc. • 01/19/2024 11:30:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:04:51 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM